Scoresby, Australia

Jun Zeng

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Glaxosmithkline LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Zeng. Retrieved from https://idiyas.com/inventor/jun-zeng-cqx0hbi0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jun Zeng: Innovator in Phenyl Amino Pyrimidine Compounds

Introduction

Jun Zeng is a notable inventor based in Scoresby, Australia. He has made significant contributions to the field of chemistry, particularly with his work on phenyl amino pyrimidine compounds. His innovative approach has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

Jun Zeng holds a patent for "Phenyl Amino Pyrimidine Compounds and Uses Thereof." This patent highlights his ability to create compounds that have potential applications in various industries. With 1 patent to his name, Zeng's work is a testament to his dedication to advancing scientific knowledge.

Career Highlights

Zeng is currently employed at GlaxoSmithKline LLC, a leading global healthcare company. His role at GlaxoSmithKline allows him to collaborate with other talented professionals in the field. His contributions to the company reflect his commitment to innovation and excellence in research.

Collaborations

Throughout his career, Jun Zeng has worked alongside esteemed colleagues such as Christopher John Burns and Andrew Craig Donohue. These collaborations have enriched his work and fostered a creative environment for developing new ideas and solutions.

Conclusion

In summary, Jun Zeng is an accomplished inventor whose work on phenyl amino pyrimidine compounds has made a significant impact in the field of chemistry. His dedication to innovation and collaboration continues to drive advancements in healthcare and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…